KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 122 filers reported holding KURA ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,168,000 | +10.1% | 63,700 | -3.5% | 0.02% | +41.7% |
| Q1 2022 | $1,061,000 | -1.5% | 65,980 | +14.7% | 0.01% | +9.1% |
| Q3 2021 | $1,077,000 | -10.9% | 57,500 | -0.9% | 0.01% | -8.3% |
| Q2 2021 | $1,209,000 | -26.3% | 58,000 | 0.0% | 0.01% | -29.4% |
| Q1 2021 | $1,640,000 | -13.4% | 58,000 | 0.0% | 0.02% | -22.7% |
| Q4 2020 | $1,894,000 | +28.8% | 58,000 | +20.8% | 0.02% | +10.0% |
| Q3 2020 | $1,471,000 | +159.0% | 48,000 | -15.9% | 0.02% | +81.8% |
| Q1 2020 | $568,000 | -73.8% | 57,100 | -63.8% | 0.01% | -67.6% |
| Q4 2019 | $2,170,000 | -14.0% | 157,800 | -5.1% | 0.03% | -27.7% |
| Q3 2019 | $2,523,000 | -11.8% | 166,300 | +14.5% | 0.05% | -4.1% |
| Q2 2019 | $2,859,000 | +488.3% | 145,200 | +395.6% | 0.05% | +81.5% |
| Q1 2019 | $486,000 | – | 29,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |